Day One Biopharmaceuticals Inc (DAWN)

Deferred Revenue

$2.00M

Quarterly · Period ending: · USD

DAWN logo

DAWN Deferred Revenue

Latest reported$2.00M
DAWN Quarterly Deferred Revenue ($0.00 → $2.00M)
High-resolution chart · PNG

DAWN deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Day One Biopharmaceuticals Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
2,000,000
2,317,000
1,847,000
1,636,000
1,554,000
1,462,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.